AcelRx Pharmaceuticals Inc (ACRX) has gained 14.71% in a Week, Should You Hold?

Thursday, August 26, 2021 11:43 AM | InvestorsObserver Analysts

Mentioned in this article

AcelRx Pharmaceuticals Inc (ACRX) has gained 14.71% in a Week, Should You Hold?

A rating of 83 puts AcelRx Pharmaceuticals Inc (ACRX) near the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. AcelRx Pharmaceuticals Inc's score of 83 means it scores higher than 83% of stocks in the industry. AcelRx Pharmaceuticals Inc also received an overall rating of 41, putting it above 41% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 139 out of the 148 industries.

ACRX has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on ACRX!

See Full ACRX Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 41 would rank higher than 41 percent of all stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With AcelRx Pharmaceuticals Inc Stock Today?

AcelRx Pharmaceuticals Inc (ACRX) stock has gained 7.34% while the S&P 500 has fallen -0.38% as of 11:41 AM on Thursday, Aug 26. ACRX has risen $0.08 from the previous closing price of $1.09 on volume of 586,679 shares. Over the past year the S&P 500 has risen 28.76% while ACRX has fallen -4.88%. ACRX lost -$0.36 per share the over the last 12 months. Click Here to get the full Stock Report for AcelRx Pharmaceuticals Inc stock.